Overview

Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy

Status:
Unknown status

Trial end date:
2019-08-20

Target enrollment:

Participant gender:

Summary

Bariatric surgery remains the most effective therapy for obesity. Postoperative nausea and vomiting (PONV) are commonly reported following bariatric surgery. The proposed study focuses on the most common bariatric procedure performed, laparoscopic sleeve gastrectomy (LSG), and aims to assess the effect of a post-operative nausea and vomiting-specific intervention. The investigators hypothesize that the intervention group will experience a reduction of nausea-related prolonged hospital stay and significantly improve patient-reported quality of recovery from surgery and quality of life.

Phase:

Phase 4

Details

Lead Sponsor:

Stony Brook University

Treatments:

Anesthetics
Aprepitant
BB 1101
Butylscopolammonium Bromide
Desflurane
Dexamethasone
Dexamethasone acetate
Dexmedetomidine
Fentanyl
Fosaprepitant
Metoclopramide
Ondansetron
Prochlorperazine
Propofol
Scopolamine
Scopolamine Hydrobromide
Sevoflurane